Beacon Therapeutics(@BeaconTx_) 's Twitter Profile Photo

Beacon Therapeutics has officially launched!

Here at Beacon, we are pursuing the development of a new generation of to treat a range of rare and prevalent .

Beacon Therapeutics has officially launched!

Here at Beacon, we are pursuing the development of a new generation of #genetherapies to treat a range of rare and prevalent #retinaldiseases.
account_circle
The Mighty(@TheMightySite) 's Twitter Profile Photo

Gene therapy could offer new opportunities to participants with to participate in clinical research studies. Click to read what gene therapy is, and learn about clinical research studies of gene therapies for adults with HAE.

by BioMarin

account_circle
Sean Carim(@carimfraiche) 's Twitter Profile Photo

🧬🧫🦠👩🏻‍🔬🧑🏻‍🔬👩‍💻🧑‍💻
, and come together 64x Bio to make accessible! And we're looking for research associates!! I specifically am for my molecular biology team. DM me if you or anyone you know is interested!

account_circle
CureCHM(@curechm) 's Twitter Profile Photo

laser-induced porcine model of outer retinal & choroidal degeneration for preclinical testing

This model is optimal for testing cell & GeneTherapies for outer retinal diseases including .
Bharti lab Dr.David Gamm UW–Madison

laser-induced porcine model of outer retinal & choroidal degeneration for preclinical testing 

This model is optimal for testing cell & GeneTherapies for outer retinal diseases including #Choroideremia.
@Kapilbharti123 Dr.David Gamm @UWMadison
account_circle
Research Features(@ResearchFeature) 's Twitter Profile Photo

Professor Richard Bucala, MD, PhD of @Yale Rheum/Allergy reveals how a commonly occurring gene variant explains the variation in symptoms & risk for severe illness. Genetic profiling could help identify high-risk individuals and improve options.

bit.ly/3McXnIr

account_circle
David Sinclair(@davidasinclair) 's Twitter Profile Photo

Aspartame in diet sodas, gum and some Snapple drinks will be listed by World Health Organization (WHO) as 'possibly carcinogenic to humans,' while a new study indicates another popular sweetener, Splenda, causes damage to DNA and the gut. Read on…

Aspartame in diet sodas, gum and some Snapple drinks will be listed by @WHO as 'possibly carcinogenic to humans,' while a new study indicates another popular sweetener, Splenda, causes damage to DNA and the gut. Read on…
account_circle
matt krebs(@krebs_matt) 's Twitter Profile Photo

Dive into the data-rich analysis from BioCentury's map of the clinical world of AAV gene therapies.

Details here (subscription or trial access required): biocentury.com/biocentury/pro…

Dive into the data-rich analysis from BioCentury's map of the #biotech clinical world of AAV gene therapies.  

Details here (subscription or trial access required): biocentury.com/biocentury/pro… #genetherapy #genetherapies #cancer
account_circle
SCIEX 🏳️‍🌈(@SCIEXnews) 's Twitter Profile Photo

Today, we debuted a breakthrough method for for the robust high-resolution determination of full, partial and empty capsid ratios for adeno-associated virus analysis. Announcement here: ow.ly/bgoK50z2Hen

Today, we debuted a breakthrough method for #genetherapies for the robust high-resolution determination of full, partial and empty capsid ratios for adeno-associated virus analysis. Announcement here: ow.ly/bgoK50z2Hen
account_circle
James (UnfilteredTruth)(@JCeltic20222) 's Twitter Profile Photo

Do you understand that they are trying to create another narrative to cover for the rise in aggressive turbo cancers cause by the experimental gene therapies

account_circle
CureCHM(@curechm) 's Twitter Profile Photo

Creating a map of RPE cells subpopulations with differential retinal diseases sensitivity.

Findings will help in developing precise cell & .

Innovative work by @davideortolan91 Ruchi Sharma @kapilbharti123 pnas.org/doi/10.1073/pn…

account_circle
Opus Genetics(@OpusGenetics) 's Twitter Profile Photo

Attending the upcoming Imaging Biomarkers & Endpoints Summit in Boston? Don't miss Opus CSO Dr. Ash Jayagopal presenting Opus work underway to advance preclinical & clinical imaging approaches to power clinical translation of retinal June 15 at 3:30 pm ET

Attending the upcoming #Retinal Imaging Biomarkers & Endpoints Summit in Boston? Don't miss Opus CSO Dr. Ash Jayagopal presenting Opus work underway to advance preclinical & clinical imaging approaches to power clinical translation of retinal #genetherapies  June 15 at 3:30 pm ET
account_circle
Institute for Gene Therapies(@gene_therapies) 's Twitter Profile Photo

Having a clear understanding of the value offer is critical to all efforts involved in delivering these transformational treatments to patients, especially those living with , the most common rare disease that predominantly impacts African Americans.

Having a clear understanding of the value #genetherapies offer is critical to all efforts involved in delivering these transformational treatments to patients, especially those living with #sicklecell, the most common rare disease that predominantly impacts African Americans.
account_circle
RegenMedPhD(@RegenMedPhD) 's Twitter Profile Photo

MANY THANKS to extraordinaire Rebecca Pender and awesome Pfizer Rare Disease Team UK for delivering June 2022 ATRM Master Class. Incredible to be learning from you - and - 😊.

MANY THANKS to #patientadvocate extraordinaire Rebecca Pender and awesome Pfizer Rare Disease Team UK for delivering June 2022 ATRM Master Class.  Incredible to be learning from you - #advancedtherapies and #genetherapies - 😊.
account_circle
Taysha Gene Therapies(@TayshaGTx) 's Twitter Profile Photo

Don’t forget – tune in to our virtual R&D Day today at 10 a.m. ET to hear the latest in the development of our investigational in giant axonal neuropathy (GAN) and Rett syndrome. bit.ly/3NPTiM3

account_circle
Actinium Pharma(@ActiniumPharma) 's Twitter Profile Photo

Actinium Announces Initiation of Patient Enrollment in Iomab-ACT Trial for Targeted Conditioning Prior to CD19 CAR T-Cell Therapy

Read the full news release here: ir.actiniumpharma.com/press-releases… $ATNM

Actinium Announces Initiation of Patient Enrollment in Iomab-ACT Trial for Targeted Conditioning Prior to CD19 CAR T-Cell Therapy

Read the full news release here: ir.actiniumpharma.com/press-releases… $ATNM #GeneTherapies #Biotech #Healthcare #BMT
account_circle
Bernard A Fox(@BernardAFox) 's Twitter Profile Photo

💥Today, After more than 3 decades service Raj K. Puri, MD, PhD, retired/As Dir Division of Cellular & Gene Therapies (DCGT) in OTAT, , U.S. FDA He played a role in approval of numerous & that improved outcomes for patients Iovance Biotherapeutics Society for Immunotherapy of Cancer THXS!

💥Today, After more than 3 decades service Raj K. Puri, MD, PhD, retired/As Dir Division of Cellular & Gene Therapies (DCGT) in OTAT, #CBER, @US_FDA He played a role in approval of numerous #cell & #GeneTherapies that improved outcomes for patients @IovanceBio @sitcancer THXS!
account_circle
#RecombEU(@recombeu) 's Twitter Profile Photo

Today is the International Neonatal Screening Day (ISND). Join ISND and help ensure that every newborn receives the necessary screenings for a healthy start in life. shorturl.at/KWX04 , , ,

account_circle
Encoded Therapeutics(@EncodedTx) 's Twitter Profile Photo

We’re developing potentially one-time, disease-modifying to treat a wide range of diseases, including rare diseases like . Join us in raising awareness next week on . Details on rarediseaseday.org.

We’re developing potentially one-time, disease-modifying #GeneTherapies to treat a wide range of diseases, including rare diseases like #DravetSyndrome. Join us in raising awareness next week on #RareDiseaseDay. Details on rarediseaseday.org. #LightUpForRare #ShareYourColors
account_circle
Science Animated(@Sci_Ani) 's Twitter Profile Photo

syndrome: Genetic caused by PIK3CA gene mutation, causing tissue overgrowth & blood vessel irregularity. CLOVES Syndrome Community supports affected individuals, educates and empowers. New uses hiPSCs to expand treatment options

youtube.com/watch?v=scM18L…

account_circle
joke de boer(@I_love_you_yes) 's Twitter Profile Photo

Never forget the connections!
Von der Leyen is a German physician. He is married to the President of the European Commission.Since December 2020, he is Medical Director of the US biotech company which is specialized in cell and . ONS KENT ONS!

Never forget the connections!
Von der Leyen is a German physician. He is married to the President of the European Commission.Since December 2020, he is Medical Director of the US biotech company #Orgenesis which is specialized in cell and #genetherapies. ONS KENT ONS!
#WEF #NWO
account_circle
Cell Therapies Pty Ltd(@CellTherapies_) 's Twitter Profile Photo

A faster path exists. Take the time to find it.

Here are five areas where you can accelerate the journey to in-human trials with careful planning and savvy decision making: celltherapies.com/the-fast-path-…

A faster path exists. Take the time to find it.

Here are five areas where you can accelerate the journey to in-human #celltherapy trials with careful planning and savvy decision making: celltherapies.com/the-fast-path-…

#genetherapies #regenmed #biotech
account_circle